PeriVision makes functional eye testing accessible to everyone and everywhere using virtual reality and AI algorithms. The start-up received a Tech Seed loan of CHF 100,000 from the Foundation for Technological Innovation (FIT), which will allow PeriVision to further develop its eye testing platform and prepare market entry in the US and Switzerland.
Virtual eye testing for the 21st century thanks to PeriVision
The elderly population, which is also most susceptible to eye disease, is growing year after year, but current eye testing technologies are stationary, expensive and unreliable. To enable earlier detection and more efficient monitoring of eye diseases, Biopôle-based PeriVision is combining commercial virtual reality and powerful recognition algorithms. The initial focus of PeriVision’s software is on glaucoma, a chronic eye disease leading to blindness and affecting 80 million patients globally.
The startup’s patented artificial intelligence algorithm and software application offer a virtual reality-form of perimetry, the eye exam used to detect visual defects and the progression of the disease. In the future, they will implement additional eye tests onto its platform and add AI tools to help eye doctors improve patient management. With the FIT Tech Seed loan, PeriVision will now continue investing into its platform development, run several clinical studies in hospitals in Switzerland, the US and UK and prepare the market entry for its first VR-perimetry product.
